Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001610618-25-000017
Filing Date
2025-03-06
Accepted
2025-03-06 16:25:45
Documents
100
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. 2024 FORM 10-K cdtx-20241231.htm   iXBRL 10-K 1855873
2 DESCRIPTION OF THE REGISTRANT'S SECURITIES exhibit452024-12.htm EX-4.5 24024
3 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY, AS AMENDED exhibit1052024-12.htm EX-10.5 16888
4 2020 INDUCEMENT INCENTIVE PLAN, AS AMENDED exhibit1072024-12.htm EX-10.7 191627
5 EXECUTIVE OFFICERS EMPLOYMENT AGREEMENT, AS AMENDED exhibit10302024-12.htm EX-10.30 59440
6 INSIDER TRADING POLICY exhibit1912024-12.htm EX-19.1 27107
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit2312024-12.htm EX-23.1 3331
8 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112024-12.htm EX-31.1 11486
9 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122024-12.htm EX-31.2 11670
10 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212024-12.htm EX-32.1 6991
11 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222024-12.htm EX-32.2 7189
17 GRAPHIC cdtx-20241231_g1.jpg GRAPHIC 436119
18 GRAPHIC cdtx-20241231_g2.jpg GRAPHIC 272194
19 GRAPHIC cdtx-20241231_g3.jpg GRAPHIC 457400
20 GRAPHIC cdtx-20241231_g4.jpg GRAPHIC 232705
21 GRAPHIC cdtx-20241231_g5.jpg GRAPHIC 47123
  Complete submission text file 0001610618-25-000017.txt   13582664

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20241231.xsd EX-101.SCH 61333
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20241231_cal.xml EX-101.CAL 113952
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20241231_def.xml EX-101.DEF 445852
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20241231_lab.xml EX-101.LAB 830492
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20241231_pre.xml EX-101.PRE 698285
103 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20241231_htm.xml XML 1237712
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36912 | Film No.: 25715649
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)